| Investigation of the Psychosocial Factors Responsible for the Late Recourse to HIV Testing Within MSM (NCT03661203) | French National Agency for Research on AIDS and Viral Hepatitis | 2020-09-01 |
| Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV (NCT03671291) | French National Agency for Research on AIDS and Viral Hepatitis | 2019-04-03 |
| MAKASI Intervention for African and Caribbean Migrants' Empowerment in Sexual Health in Paris Greater Area (NCT04468724) | French National Agency for Research on AIDS and Viral Hepatitis | 2019-02-01 |
| Cohort Study on People Who Inject Drugs in Senegal (NCT03459768) | French National Agency for Research on AIDS and Viral Hepatitis | 2016-08-24 |
| Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation (NCT01463956) | French National Agency for Research on AIDS and Viral Hepatitis | 2012-01-06 |
| Lenalidomide in Kaposi Disease Associated With HIV Infection (NCT01282047) | French National Agency for Research on AIDS and Viral Hepatitis | 2011-10-01 |
| The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient. (NCT01426243) | French National Agency for Research on AIDS and Viral Hepatitis | 2011-07-01 |
| Residual Risk Assessment Of HIV Transmission (NCT01413152) | French National Agency for Research on AIDS and Viral Hepatitis | 2011-07-01 |
| Efficacy of Vitamin D on Top of Pegylated Interferon and Ribavirin in Patients With Chronic Viral Hepatitis C Null-Responders (NCT01226446) | French National Agency for Research on AIDS and Viral Hepatitis | 2010-11-01 |
| Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam (NCT00651066) | French National Agency for Research on AIDS and Viral Hepatitis | 2010-06-01 |
| Cohort of Young Adults Infected With HIV Since Birth or During Childhood (NCT01269632) | French National Agency for Research on AIDS and Viral Hepatitis | 2010-06-01 |
| Feasibility and Limitations of Offering Community Based Rapid HIV Testing to Men Who Have Sex With Men (MSM) (NCT01164462) | French National Agency for Research on AIDS and Viral Hepatitis | 2010-03-01 |
| Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial (NCT00936195) | French National Agency for Research on AIDS and Viral Hepatitis | 2010-01-01 |
| Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance (NCT00927290) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-12-03 |
| Incidence of H1N1v Influenza-like Illness and Risk Factors for Serious Influenza Forms in HIV Infected Patients (NCT01039220) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-12-01 |
| Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding (NCT00640263) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-12-01 |
| Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients (NCT00946595) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-11-01 |
| Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac) (NCT01008813) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-10-01 |
| Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration (NCT00944541) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-09-01 |
| Accelerated Aging, HIV Infection, Antiretroviral Therapies (NCT01038999) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-04-01 |
| Patients Infected With HIV Since More Than 10 Years With a Plasma Viral RNA <400 Copies / mL in the Absence of Any Treatment: Study Mechanisms Involved in Controlling the Infection (NCT01065207) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-03-01 |
| Couple-oriented Prenatal HIV Counseling in Low and Medium HIV Prevalence Countries (NCT01494961) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-02-01 |
| Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa (NCT00640887) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-02-01 |
| Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices (NCT00657397) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-01-01 |
| ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy (NCT00823342) | French National Agency for Research on AIDS and Viral Hepatitis | 2008-12-14 |
| Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA) (NCT00573001) | French National Agency for Research on AIDS and Viral Hepatitis | 2008-07-01 |
| Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO) (NCT00495651) | French National Agency for Research on AIDS and Viral Hepatitis | 2008-03-01 |
| Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-related Vasculitis Patients (NCT00574652) | French National Agency for Research on AIDS and Viral Hepatitis | 2008-03-01 |
| Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada (NCT00528060) | French National Agency for Research on AIDS and Viral Hepatitis | 2008-01-01 |
| Efficacy and Tolerance of Naked DNA Vaccine in Patients With Chronic B Hepatitis (NCT00536627) | French National Agency for Research on AIDS and Viral Hepatitis | 2008-01-01 |
| Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2) (NCT00623051) | French National Agency for Research on AIDS and Viral Hepatitis | 2008-01-01 |
| Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT (NCT00647205) | French National Agency for Research on AIDS and Viral Hepatitis | 2008-01-01 |
| Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO) (NCT00495326) | French National Agency for Research on AIDS and Viral Hepatitis | 2007-12-01 |
| Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women (NCT01311752) | French National Agency for Research on AIDS and Viral Hepatitis | 2007-11-01 |
| Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load (NCT00454337) | French National Agency for Research on AIDS and Viral Hepatitis | 2007-05-01 |
| Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses (NCT00460382) | French National Agency for Research on AIDS and Viral Hepatitis | 2007-05-01 |
| Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136 (NCT00421551) | French National Agency for Research on AIDS and Viral Hepatitis | 2007-03-01 |
| Immunology of the Infection Perinatal (NCT01055873) | French National Agency for Research on AIDS and Viral Hepatitis | 2007-02-01 |
| Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy. (NCT00432419) | French National Agency for Research on AIDS and Viral Hepatitis | 2007-02-01 |
| Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients (NCT00391638) | French National Agency for Research on AIDS and Viral Hepatitis | 2007-01-01 |
| Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE (NCT00383734) | French National Agency for Research on AIDS and Viral Hepatitis | 2006-12-01 |
| Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA) (NCT00334256) | French National Agency for Research on AIDS and Viral Hepatitis | 2006-10-01 |
| Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL) (NCT00301561) | French National Agency for Research on AIDS and Viral Hepatitis | 2006-05-01 |
| Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130) (NCT00302822) | French National Agency for Research on AIDS and Viral Hepatitis | 2006-04-01 |
| Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME) (NCT00122538) | French National Agency for Research on AIDS and Viral Hepatitis | 2006-02-01 |
| Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA) (NCT00226434) | French National Agency for Research on AIDS and Viral Hepatitis | 2006-01-01 |
| Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129) (NCT00115609) | French National Agency for Research on AIDS and Viral Hepatitis | 2006-01-01 |
| Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127) (NCT00122603) | French National Agency for Research on AIDS and Viral Hepatitis | 2005-12-01 |
| Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126) (NCT00117494) | French National Agency for Research on AIDS and Viral Hepatitis | 2005-10-01 |
| Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin (NCT00196664) | French National Agency for Research on AIDS and Viral Hepatitis | 2005-10-01 |
| Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2) (NCT00120796) | French National Agency for Research on AIDS and Viral Hepatitis | 2005-08-01 |
| Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125) (NCT00120367) | French National Agency for Research on AIDS and Viral Hepatitis | 2005-04-01 |
| Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120) (NCT00120757) | French National Agency for Research on AIDS and Viral Hepatitis | 2004-10-01 |
| Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis (NCT00148837) | French National Agency for Research on AIDS and Viral Hepatitis | 2004-09-01 |
| AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers (NCT00121758) | French National Agency for Research on AIDS and Viral Hepatitis | 2004-09-01 |
| Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding (NCT00158509) | French National Agency for Research on AIDS and Viral Hepatitis | 2004-08-01 |
| Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers (NCT00121121) | French National Agency for Research on AIDS and Viral Hepatitis | 2004-07-01 |
| Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123) (NCT00113282) | French National Agency for Research on AIDS and Viral Hepatitis | 2004-06-01 |
| Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C (NCT00148863) | French National Agency for Research on AIDS and Viral Hepatitis | 2004-06-01 |
| Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207) (NCT00158457) | French National Agency for Research on AIDS and Viral Hepatitis | 2004-06-01 |
| Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119) (NCT00120185) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-12-01 |
| Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C (NCT00122616) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-11-01 |
| Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients (NCT00122668) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-11-01 |
| Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR) (NCT00158470) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-09-01 |
| Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers (NCT00122564) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-06-01 |
| Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212) (NCT00158483) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-05-01 |
| Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy (NCT00127569) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-05-01 |
| Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients (NCT00196586) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-04-01 |
| Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients (NCT00148850) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-02-01 |
| Long-Term Supervised Treatment Interruption in HIV-Infected Patients (NCT00118677) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-02-01 |
| Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213) (NCT00158522) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-02-01 |
| Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN) (NCT00158405) | French National Agency for Research on AIDS and Viral Hepatitis | 2002-12-01 |
| Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211) (NCT00158496) | French National Agency for Research on AIDS and Viral Hepatitis | 2002-08-01 |
| Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART) (NCT00122590) | French National Agency for Research on AIDS and Viral Hepatitis | 2002-07-01 |
| Effect of Male Circumcision on HIV Incidence (ANRS 1265) (NCT00122525) | French National Agency for Research on AIDS and Viral Hepatitis | 2002-07-01 |
| Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection (NCT00196638) | French National Agency for Research on AIDS and Viral Hepatitis | 2002-05-01 |
| Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients (NCT00122577) | French National Agency for Research on AIDS and Viral Hepatitis | 2002-03-01 |
| Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C (NCT00119119) | French National Agency for Research on AIDS and Viral Hepatitis | 2002-02-01 |
| Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance (NCT00120783) | French National Agency for Research on AIDS and Viral Hepatitis | 2002-02-01 |
| Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression (NCT00125814) | French National Agency for Research on AIDS and Viral Hepatitis | 2001-12-01 |
| Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART) (NCT00122551) | French National Agency for Research on AIDS and Viral Hepatitis | 2001-12-01 |
| Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy (NCT00122655) | French National Agency for Research on AIDS and Viral Hepatitis | 2001-01-01 |
| Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders (NCT00122629) | French National Agency for Research on AIDS and Viral Hepatitis | 2000-10-01 |
| HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection (NCT00196651) | French National Agency for Research on AIDS and Viral Hepatitis | 2000-08-01 |
| Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma (NCT00126243) | French National Agency for Research on AIDS and Viral Hepatitis | 1999-01-01 |
| Prospective Observational Cohort Study on Mother to Child Transmission HIV1/HIV2 and Prevention (NCT03235310) | French National Agency for Research on AIDS and Viral Hepatitis | 1997-07-01 |